EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

EDIL3 promotes apoptosis resistance through an integrin αvβ5-KLF2-CDC20 axis in endometriosis

Deyu Zhang, Jingwen Zhu, Peili Wu, Yan Huang, Xiaorong Wang, Chao Peng, Yingfang Zhou, Qing Xue

Current Molecular Pharmacology · 2026 · 19 (1) · 353-371

DOI: 10.1016/j.cmp.2026.09.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Molecular Pharmacology, 2026. Verfasst von Deyu Zhang und 7 weiteren Autor:innen. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Peking University First Hospital, National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Peking University First Hospital
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, D., Zhu, J., Wu, P., Huang, Y., Wang, X., Peng, C., Zhou, Y., & Xue, Q. (2026). EDIL3 promotes apoptosis resistance through an integrin αvβ5-KLF2-CDC20 axis in endometriosis. Current Molecular Pharmacology, 19(1), 353-371. https://doi.org/10.1016/j.cmp.2026.09.004

Vancouver

Zhang D, Zhu J, Wu P, Huang Y, Wang X, Peng C, et al. EDIL3 promotes apoptosis resistance through an integrin αvβ5-KLF2-CDC20 axis in endometriosis. Current Molecular Pharmacology. 2026;19(1):353-371. doi:10.1016/j.cmp.2026.09.004

BibTeX
@article{Zhang2026,
  author = {Zhang, Deyu and Zhu, Jingwen and Wu, Peili and Huang, Yan and Wang, Xiaorong and Peng, Chao and Zhou, Yingfang and Xue, Qing},
  title = {EDIL3 promotes apoptosis resistance through an integrin αvβ5-KLF2-CDC20 axis in endometriosis},
  journal = {Current Molecular Pharmacology},
  year = {2026},
  volume = {19},
  number = {1},
  pages = {353--371},
  doi = {10.1016/j.cmp.2026.09.004}
}
Kostenlos starten →